Research paperDiscovery of novel anti-angiogenesis agents. Part 8: Diaryl thiourea bearing 1H-indazole-3-amine as multi-target RTKs inhibitors

Add time:08/18/2019    Source:sciencedirect.com

VEGFR-2, TIE-2, and EphB4 are essential for both angiogenesis and tumorigenesis. Herein, we designed and prepared three classes of multi-target inhibitors based on the extensive sequence homology along the kinase domain of angiogenic RTKs. Biological evaluation indicated that these multi-target inhibitors exhibited considerable potential as novel anti-angiogeneic and anticancer agents. Among them, a diaryl thiourea bearing 1H-indazole-3-amine (16a) displayed the most potent RTK inhibition and excellent selectivity. It also showed inhibition on viability of human umbilical vein endothelial cells and anti-proliferation against a broad spectrum of cancer cells. Therefore, 1H-indazole-3-amine could serve as a promising hinge binding group for multi-target inhibitors of VEGFR-2, Tie-2, and EphB4.

We also recommend Trading Suppliers and Manufacturers of 6-TRIFLUOROMETHOXY-PYRIDIN-3-YLAMINE (cas 135900-33-3). Pls Click Website Link as below: cas 135900-33-3 suppliers

Prev:Synthesis and properties of 4′-C-aminoalkyl-2′-fluoro-modified RNA oligomers
Next:Research paperDiscovery of novel anti-angiogenesis agents. Part 6: Multi-targeted RTK inhibitors)